NCT02485028View on ClinicalTrials.gov

Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Drug Interaction Potentiation
Interventions
DRUG

Dapoxetine 30mg tablet

DRUG

Mirodenafil 50mg tablet

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT02485028 - Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg | Biotech Hunter | Biotech Hunter